Segmented filamentous bacteria reprogramming of alveolar macrophages limits postinfluenza bacterial pneumonia
Science Immunology · 2026
DOI: 10.1126/sciimmunol.adt8858 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, 2026. Verfasst von Vu L Ngo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta GA 30303, USA. Hauptthemen laut MEDLINE: Macrophages, Alveolar, Pneumonia, Bacterial, Orthomyxoviridae Infections. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases.
Abstract (Originalsprache)
Respiratory viral infection induces depletion and dysfunction of alveolar macrophages (AMs), resulting in high-susceptibility to life-threatening bacterial pneumonia. Colonization of the intestine by segmented filamentous bacteria (SFB) reprograms AM to resist depletion. Hence, we examined whether SFB protected mice against secondary bacterial infection by Streptococcus pneumoniae , Haemophilus influenzae , or Staphylococcus aureus after influenza A virus (IAV) infection. SFB protected mice against these infections based on pathogen loads and disease symptoms. AM depletion and transplant indicated that SFB-induced AM reprogramming was necessary and sufficient for such protection. Ex vivo analysis revealed that AMs from SFB-colonized mice not only resisted IAV-induced depletion but also were epigenetically reprogrammed to preferentially use oxidative phosphorylation and complement-dependent phagocytosis, which enabled efficient killing of bacteria. AM from SFB-colonized mice held their enhanced antibacterial phenotype even when transplanted into an inflamed interferon-rich post–IAV environment. Thus, gut microbiota composition influences susceptibility to bacterial pneumonia, especially after respiratory viral infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Center for Translational Antiviral Research, Georgia State University Institute for Biomedical Sciences, Atlanta GA 30303, USA.
- Center for Inflammation, Immunity & Infection, Georgia State University Institute for Biomedical Sciences, Atlanta GA 30303, USA.
ORCID-Profile: Vu L Ngo, Carolin M Lieber, Hirohito Abo, Michal Kuczma, Richard K Plemper, Andrew T Gewirtz
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Ngo, V. L., Lieber, C. M., Abo, H., Kuczma, M., Zou, J., Plemper, R. K., & Gewirtz, A. T. (2026). Segmented filamentous bacteria reprogramming of alveolar macrophages limits postinfluenza bacterial pneumonia. Science Immunology. https://doi.org/10.1126/sciimmunol.adt8858
Vancouver
Ngo VL, Lieber CM, Abo H, Kuczma M, Zou J, Plemper RK, et al. Segmented filamentous bacteria reprogramming of alveolar macrophages limits postinfluenza bacterial pneumonia. Science Immunology. 2026. doi:10.1126/sciimmunol.adt8858
BibTeX
@article{Ngo2026,
author = {Ngo, Vu L and Lieber, Carolin M and Abo, Hirohito and Kuczma, Michal and Zou, Jun and Plemper, Richard K and Gewirtz, Andrew T},
title = {Segmented filamentous bacteria reprogramming of alveolar macrophages limits postinfluenza bacterial pneumonia},
journal = {Science Immunology},
year = {2026},
doi = {10.1126/sciimmunol.adt8858}
}
EUVIMED